First United Bank & Trust Has $750,000 Stake in CME Group Inc. (NASDAQ:CME)

First United Bank & Trust increased its stake in shares of CME Group Inc. (NASDAQ:CME) by 10.2% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,400 shares of the financial services provider’s stock after acquiring an additional 315 shares during the period. First United Bank & Trust’s holdings in CME Group were worth $750,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in CME. Swedbank AB grew its position in CME Group by 0.8% in the third quarter. Swedbank AB now owns 71,050 shares of the financial services provider’s stock valued at $15,677,000 after purchasing an additional 542 shares in the last quarter. Fruth Investment Management bought a new position in CME Group in the third quarter valued at $220,000. Creative Planning grew its position in CME Group by 9.3% in the third quarter. Creative Planning now owns 51,255 shares of the financial services provider’s stock valued at $11,309,000 after purchasing an additional 4,354 shares in the last quarter. Grove Bank & Trust grew its position in CME Group by 1.3% in the third quarter. Grove Bank & Trust now owns 4,276 shares of the financial services provider’s stock valued at $943,000 after purchasing an additional 55 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. grew its position in CME Group by 62.2% in the third quarter. Thurston Springer Miller Herd & Titak Inc. now owns 193 shares of the financial services provider’s stock valued at $43,000 after purchasing an additional 74 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Trading Up 0.3 %

Shares of CME Group stock opened at $224.82 on Wednesday. The firm has a market capitalization of $80.95 billion, a PE ratio of 25.58, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm’s 50 day moving average is $215.60 and its 200 day moving average is $208.01. CME Group Inc. has a 1 year low of $190.70 and a 1 year high of $226.78.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.53 by $0.03. The company had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s revenue was up 12.7% on a year-over-year basis. During the same period in the previous year, the firm posted $2.30 EPS. Equities research analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.05%. The ex-dividend date of this dividend was Monday, September 9th. CME Group’s payout ratio is 52.33%.

Insiders Place Their Bets

In other CME Group news, CFO Lynne Fitzpatrick sold 754 shares of the business’s stock in a transaction that occurred on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction on Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the sale, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction on Friday, August 30th. The shares were sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares in the company, valued at approximately $11,932,706.13. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on the stock. Citigroup lifted their price objective on shares of CME Group from $240.00 to $250.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. JPMorgan Chase & Co. lifted their target price on shares of CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Barclays lifted their target price on shares of CME Group from $209.00 to $219.00 and gave the stock an “equal weight” rating in a report on Monday, October 7th. Finally, Deutsche Bank Aktiengesellschaft lifted their target price on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a report on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $219.53.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.